These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 18473913)

  • 1. CDK9 a potential target for drug development.
    Canduri F; Perez PC; Caceres RA; de Azevedo WF
    Med Chem; 2008 May; 4(3):210-8. PubMed ID: 18473913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The structure of P-TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylation.
    Baumli S; Lolli G; Lowe ED; Troiani S; Rusconi L; Bullock AN; Debreczeni JE; Knapp S; Johnson LN
    EMBO J; 2008 Jul; 27(13):1907-18. PubMed ID: 18566585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory functions of Cdk9 and of cyclin T1 in HIV tat transactivation pathway gene expression.
    Romano G; Kasten M; De Falco G; Micheli P; Khalili K; Giordano A
    J Cell Biochem; 1999 Dec; 75(3):357-68. PubMed ID: 10536359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of HIV-1 replication by P-TEFb inhibitors DRB, seliciclib and flavopiridol correlates with release of free P-TEFb from the large, inactive form of the complex.
    Biglione S; Byers SA; Price JP; Nguyen VT; Bensaude O; Price DH; Maury W
    Retrovirology; 2007 Jul; 4():47. PubMed ID: 17625008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tat-associated kinase, TAK, activity is regulated by distinct mechanisms in peripheral blood lymphocytes and promonocytic cell lines.
    Herrmann CH; Carroll RG; Wei P; Jones KA; Rice AP
    J Virol; 1998 Dec; 72(12):9881-8. PubMed ID: 9811724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimized chimeras between kinase-inactive mutant Cdk9 and truncated cyclin T1 proteins efficiently inhibit Tat transactivation and human immunodeficiency virus gene expression.
    Fujinaga K; Irwin D; Geyer M; Peterlin BM
    J Virol; 2002 Nov; 76(21):10873-81. PubMed ID: 12368330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin box structure of the P-TEFb subunit cyclin T1 derived from a fusion complex with EIAV tat.
    Anand K; Schulte A; Fujinaga K; Scheffzek K; Geyer M
    J Mol Biol; 2007 Jul; 370(5):826-36. PubMed ID: 17540406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-loop phosphorylated Cdk9 localizes to nuclear speckle domains which may serve as sites of active P-TEFb function and exchange between the Brd4 and 7SK/HEXIM1 regulatory complexes.
    Dow EC; Liu H; Rice AP
    J Cell Physiol; 2010 Jul; 224(1):84-93. PubMed ID: 20201073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human immunodeficiency virus type 1 replication by RNA interference directed against human transcription elongation factor P-TEFb (CDK9/CyclinT1).
    Chiu YL; Cao H; Jacque JM; Stevenson M; Rana TM
    J Virol; 2004 Mar; 78(5):2517-29. PubMed ID: 14963154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CDK9: from basal transcription to cancer and AIDS.
    De Falco G; Giordano A
    Cancer Biol Ther; 2002; 1(4):342-7. PubMed ID: 12432243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential localization and expression of the Cdk9 42k and 55k isoforms.
    Liu H; Herrmann CH
    J Cell Physiol; 2005 Apr; 203(1):251-60. PubMed ID: 15452830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor gamma recruits the positive transcription elongation factor b complex to activate transcription and promote adipogenesis.
    Iankova I; Petersen RK; Annicotte JS; Chavey C; Hansen JB; Kratchmarova I; Sarruf D; Benkirane M; Kristiansen K; Fajas L
    Mol Endocrinol; 2006 Jul; 20(7):1494-505. PubMed ID: 16484339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MD simulation of the Tat/Cyclin T1/CDK9 complex revealing the hidden catalytic cavity within the CDK9 molecule upon Tat binding.
    Asamitsu K; Hirokawa T; Okamoto T
    PLoS One; 2017; 12(2):e0171727. PubMed ID: 28178316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coordination of transcription factor phosphorylation and histone methylation by the P-TEFb kinase during human immunodeficiency virus type 1 transcription.
    Zhou M; Deng L; Lacoste V; Park HU; Pumfery A; Kashanchi F; Brady JN; Kumar A
    J Virol; 2004 Dec; 78(24):13522-33. PubMed ID: 15564463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The emerging picture of CDK9/P-TEFb: more than 20 years of advances since PITALRE.
    Paparidis NF; Durvale MC; Canduri F
    Mol Biosyst; 2017 Jan; 13(2):246-276. PubMed ID: 27833949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bromodomain protein Brd4 regulates human immunodeficiency virus transcription through phosphorylation of CDK9 at threonine 29.
    Zhou M; Huang K; Jung KJ; Cho WK; Klase Z; Kashanchi F; Pise-Masison CA; Brady JN
    J Virol; 2009 Jan; 83(2):1036-44. PubMed ID: 18971272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcription elongation factor P-TEFb mediates Tat activation of HIV-1 transcription at multiple stages.
    Zhou Q; Chen D; Pierstorff E; Luo K
    EMBO J; 1998 Jul; 17(13):3681-91. PubMed ID: 9649438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin Dependent Kinase 9 Inhibitors for Cancer Therapy.
    Sonawane YA; Taylor MA; Napoleon JV; Rana S; Contreras JI; Natarajan A
    J Med Chem; 2016 Oct; 59(19):8667-8684. PubMed ID: 27171036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclin-dependent kinase 9 activity regulates neutrophil spontaneous apoptosis.
    Wang K; Hampson P; Hazeldine J; Krystof V; Strnad M; Pechan P; M J
    PLoS One; 2012; 7(1):e30128. PubMed ID: 22276149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The HIV-1 Tat Protein: Mechanism of Action and Target for HIV-1 Cure Strategies.
    Rice AP
    Curr Pharm Des; 2017; 23(28):4098-4102. PubMed ID: 28677507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.